Market Cap 20.74B
Revenue (ttm) 11.04B
Net Income (ttm) 992.00M
EPS (ttm) N/A
PE Ratio 18.82
Forward PE 17.79
Profit Margin 8.99%
Debt to Equity Ratio 0.74
Volume 762,500
Avg Vol 922,990
Day's Range N/A - N/A
Shares Out 110.70M
Stochastic %K 9%
Beta 0.60
Analysts Sell
Price Target $223.00

Company Profile

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, go...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 973 520 2700
Address:
500 Plaza Drive, Secaucus, United States
InvestingWithRob
InvestingWithRob May. 8 at 12:57 PM
$DGX AI health analysis market… that’s all you need to know. Could see a super growth cycle
0 · Reply
Biologics
Biologics May. 7 at 8:09 PM
$DGX My recent article on Quest Diagnostics Q1 Earnings
0 · Reply
JoshMck
JoshMck May. 7 at 5:33 PM
$DGX guess I’m buy happy today. Added to my $HIMS position. Started in $CELH after a good long pullback, now I’m starting a position here. Got a hunch medical testing is gonna start showing up on radars and I like where this is. Maybe I’m wrong? Can’t make money sitting out.
0 · Reply
BillionerOfKing
BillionerOfKing May. 6 at 11:03 PM
$DGX Current Stock Price: $189.15 Contracts to trade: $190.0 DGX May 15 2026 Call Entry: $2.00 Exit: $3.28 ROI: 64% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
CapitalMonk
CapitalMonk May. 6 at 6:03 PM
$DGX Price: $189.85 (-0.52%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.37% RSI: 48.0 | Momentum: Moderate Volume: -81.3% vs avg Volatility: 1.79% Support: $187.50 | Resistance: $209.79 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
LiveCommander
LiveCommander Apr. 24 at 11:16 PM
Tech companies don’t all pay the same way. Some rely on scale. $ORCL $CSCO Others rely on growth. $CRM Others rely on demand. $DELL Others rely on volume. $DGX Different paths. Same result. Income. Which one pays you?
0 · Reply
TalkMarkets
TalkMarkets Apr. 24 at 8:51 AM
These Companies Are Raising Guidance This Earnings Season $UNH $DGX https://talkmarkets.com/article/these-companies-are-raising-guidance-this-earnings-season-1777020550
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Apr. 23 at 3:57 PM
0 · Reply
NorthStarStats
NorthStarStats Apr. 23 at 9:53 AM
Output from a custom NorthStarStats momentum scanner highlighting stocks with strengthening price structure and momentum. Setups to watch and study — not trade recommendations. $ISRG Score 100, $ADBE Score 100, $IBM Score 100, $DGX Score 98, $BTBT Score 90
0 · Reply
Gianluca_Trader
Gianluca_Trader Apr. 22 at 4:10 PM
sold a put on $DGX post-earnings. IV didn't crush like usual so premium is still juicy (IV rank >80%). Cycles point to a turning point up from here, and I'm fine owning the shares if assigned since I picked a good strike price for long term investment https://optionsamurai.com/blog/trade-idea-naked-put-dgx/
0 · Reply
Latest News on DGX
Quest Diagnostics Prices $500 Million of Senior Notes

Apr 27, 2026, 4:10 PM EDT - 13 days ago

Quest Diagnostics Prices $500 Million of Senior Notes


Quest Diagnostics Earnings Call Transcript: Q1 2026

Apr 21, 2026, 8:30 AM EDT - 19 days ago

Quest Diagnostics Earnings Call Transcript: Q1 2026


Digi Power X Graduates to Cboe Canada

Feb 27, 2026, 10:00 AM EST - 2 months ago

Digi Power X Graduates to Cboe Canada


Quest Diagnostics price target raised to $210 from $190 at UBS

2026-02-11T14:16:12.000Z - 3 months ago

Quest Diagnostics price target raised to $210 from $190 at UBS


Quest Diagnostics Earnings Call Transcript: Q4 2025

Feb 10, 2026, 8:30 AM EST - 3 months ago

Quest Diagnostics Earnings Call Transcript: Q4 2025


Quest Diagnostics Transcript: 7th Annual Healthcare Symposium

Nov 14, 2025, 8:50 AM EST - 6 months ago

Quest Diagnostics Transcript: 7th Annual Healthcare Symposium


Quest Diagnostics Declares Quarterly Cash Dividend

Nov 11, 2025, 4:22 PM EST - 6 months ago

Quest Diagnostics Declares Quarterly Cash Dividend


Quest Diagnostics Earnings Call Transcript: Q3 2025

Oct 21, 2025, 8:30 AM EDT - 7 months ago

Quest Diagnostics Earnings Call Transcript: Q3 2025


Quest Diagnostics Earnings Call Transcript: Q2 2025

Jul 22, 2025, 8:30 AM EDT - 10 months ago

Quest Diagnostics Earnings Call Transcript: Q2 2025


Quest Diagnostics Introduces Testing for Oropouche Virus

Jul 15, 2025, 7:57 AM EDT - 10 months ago

Quest Diagnostics Introduces Testing for Oropouche Virus


Quest Diagnostics Releases 2024 Corporate Responsibility Report

Jun 25, 2025, 9:07 AM EDT - 11 months ago

Quest Diagnostics Releases 2024 Corporate Responsibility Report


InvestingWithRob
InvestingWithRob May. 8 at 12:57 PM
$DGX AI health analysis market… that’s all you need to know. Could see a super growth cycle
0 · Reply
Biologics
Biologics May. 7 at 8:09 PM
$DGX My recent article on Quest Diagnostics Q1 Earnings
0 · Reply
JoshMck
JoshMck May. 7 at 5:33 PM
$DGX guess I’m buy happy today. Added to my $HIMS position. Started in $CELH after a good long pullback, now I’m starting a position here. Got a hunch medical testing is gonna start showing up on radars and I like where this is. Maybe I’m wrong? Can’t make money sitting out.
0 · Reply
BillionerOfKing
BillionerOfKing May. 6 at 11:03 PM
$DGX Current Stock Price: $189.15 Contracts to trade: $190.0 DGX May 15 2026 Call Entry: $2.00 Exit: $3.28 ROI: 64% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
CapitalMonk
CapitalMonk May. 6 at 6:03 PM
$DGX Price: $189.85 (-0.52%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.37% RSI: 48.0 | Momentum: Moderate Volume: -81.3% vs avg Volatility: 1.79% Support: $187.50 | Resistance: $209.79 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
LiveCommander
LiveCommander Apr. 24 at 11:16 PM
Tech companies don’t all pay the same way. Some rely on scale. $ORCL $CSCO Others rely on growth. $CRM Others rely on demand. $DELL Others rely on volume. $DGX Different paths. Same result. Income. Which one pays you?
0 · Reply
TalkMarkets
TalkMarkets Apr. 24 at 8:51 AM
These Companies Are Raising Guidance This Earnings Season $UNH $DGX https://talkmarkets.com/article/these-companies-are-raising-guidance-this-earnings-season-1777020550
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Apr. 23 at 3:57 PM
0 · Reply
NorthStarStats
NorthStarStats Apr. 23 at 9:53 AM
Output from a custom NorthStarStats momentum scanner highlighting stocks with strengthening price structure and momentum. Setups to watch and study — not trade recommendations. $ISRG Score 100, $ADBE Score 100, $IBM Score 100, $DGX Score 98, $BTBT Score 90
0 · Reply
Gianluca_Trader
Gianluca_Trader Apr. 22 at 4:10 PM
sold a put on $DGX post-earnings. IV didn't crush like usual so premium is still juicy (IV rank >80%). Cycles point to a turning point up from here, and I'm fine owning the shares if assigned since I picked a good strike price for long term investment https://optionsamurai.com/blog/trade-idea-naked-put-dgx/
0 · Reply
EarningsCentral
EarningsCentral Apr. 22 at 3:24 AM
$DGX Quest Diagnostics Q1 2026 Earnings | AI, Alzheimer’s Test, HUGE Growth https://youtu.be/Op0OamL3IGU
0 · Reply
NorthStarStats
NorthStarStats Apr. 22 at 2:19 AM
Output from a custom NorthStarStats momentum scanner highlighting stocks with strengthening price structure and momentum. Setups to watch and study — not trade recommendations. Low scores again today. Approach any momentum trades with caution. Go slow and go low. $DGX Score 100, $IBM Score 95, $TRV Score 90, $EXEL Score 73, $FFIV Score 70
0 · Reply
Small_time_trader
Small_time_trader Apr. 21 at 3:07 PM
$DGX Under reaction based on the numbers Again another nice beat / raise Should be up even more
0 · Reply
OpenOutcrier
OpenOutcrier Apr. 21 at 12:27 PM
$DGX (+3.3% pre) Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026 https://ooc.bz/l/99426
0 · Reply
mikesterz7
mikesterz7 Apr. 21 at 11:14 AM
$DGX 🚨🚨🚨 Strong top-line growth: Q1 2026 net revenues rose to $2.90 billion, up 9.2% year over year, with 9.0% organic revenue growth and 10.9% higher requisition volume. Double-digit earnings expansion: Reported diluted EPS increased 15.5% to $2.24 and adjusted diluted EPS grew 13.1% to $2.50, supported by higher operating income and margin. Guidance raised: Full year 2026 net revenues are now projected at $11.78–$11.90 billion and adjusted diluted EPS at $10.63–$10.83, both above prior guidance ranges.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Apr. 21 at 10:55 AM
$DGX Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $2.27 up 15.23% YoY • Reported revenue of $2.9B up 9.16% YoY • Quest Diagnostics updated full year 2026 guidance, projecting net revenues to increase 6.8% to 7.8%. Reported diluted EPS is expected to be $9.58 to $9.78, and adjusted diluted EPS $10.63 to $10.83.
0 · Reply
Estimize
Estimize Apr. 21 at 10:00 AM
$DGX reported - EPS and - revenue for Q1. http://www.estimize.com/intro/dgx?chart=historical&metric_name=eps&utm_content=DGX&utm_medium=act
0 · Reply
Sambong
Sambong Apr. 16 at 4:20 PM
$DGX a good long candidate with 190 stop
1 · Reply
BreakoutsHappen
BreakoutsHappen Apr. 7 at 4:34 PM
VCP Scanner Today: $DGX $UNF https://breakoutshappen.com/scanners/vcp-scanner
0 · Reply
DavyDaveCharts
DavyDaveCharts Mar. 24 at 5:16 PM
$DGX weekly: basing in low 190s for launch pad to 213.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 21 at 12:50 AM
$DGX RSI: 17.05, MACD: -0.5481 Vol: 5.70, MA20: 203.19, MA50: 195.37 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ZacksResearch
ZacksResearch Mar. 10 at 1:08 PM
$DGX poised for growth despite macro headwinds 🚀 Quest Diagnostics' investments in advanced diagnostics and strategic acquisitions show potential, with a 16.5% stock rally in the past year and earnings surprises in each of the last four quarters. However, a debt-laden balance sheet and economic pressures could pose challenges. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2881329/should-you-continue-to-hold-dgx-stock-in-your-portfolio?cid=sm-stocktwits-2-2881329-body-36690&ADID=SYND_STOCKTWITS_TWEET_2_2881329_BODY_36690
0 · Reply